Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
Daily MedNews
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Getting Bad News May Be Better Than Not Knowing at All, Study Says
No news is good news, right?
Not necessarily, University of Toronto researchers...
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Forward-Facing Strollers May Stress Babies
Using forward-facing strollers may cause babies emotional distress because they aren't getting...
SATURDAY, Nov. 22 -- You can eat healthier this holiday season by altering recipes and making good food choices, say experts with the Texas AgriLife Extension Service.
Holiday cooks can reduce the sugar, fat or salt content of almost any holiday...
FRIDAY, Nov. 21 -- It's one of medicine's mantras: If you have high blood pressure, taking steps to lower it will have a dramatic impact on your risk of stroke, heart disease and more.
But 70 percent of people with high blood pressure still aren't...
FRIDAY, Nov. 21 -- Latina women are almost six times more likely than white women to report great dissatisfaction and regret about their choice of breast cancer treatment, a new report says.
Researchers at the University of Michigan Comprehensive...
Pharma Industry News
SAN MATEO, Calif., November 21, 2008 /PRNewswire/ -- Just three days after the JUPITER trial results were presented at the American Heart Association meeting and simultaneously published online by the New England Journal of Medicine, an AlphaDetail...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 20, 2008 - Targanta Therapeutics Corporation (Nasdaq: TARG) today announced that oritavancin, the Company's investigational antibiotic therapy for the treatment of complicated skin and skin structure infections...
CHICAGO, Nov. 18, 2008—An analysis of randomized controlled trials indicates that use of the cancer drug bevacizumab is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs),...
JERUSALEM--(BUSINESS WIRE)--Nov 19, 2008 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) to market its...
BETHESDA, Md., Nov. 18, 2008-In contrast to recent findings, two of the most common medications used to treat attention deficit hyperactivity disorder (ADHD) do not appear to cause genetic damage in children who take them as prescribed, according to...
New Drug Approvals
RARITAN, N.J., November 21, 2008 /PRNewswire/ -- Millions of Americans with moderate to severe acute pain and their health-care providers will soon have a new treatment option. Today, Johnson & Johnson Pharmaceutical Research & Development, L.L.C.,...
PHILADELPHIA, November 20, 2008 /PRNewswire-FirstCall/ --GlaxoSmithKline today announced that the United States Food and Drug Administration (FDA) granted accelerated approval for Promacta (eltrombopag) for the treatment of thrombocytopenia in...
LONDON, Nov. 19, 2008-On 18 November 2008, the US FDA responded to AstraZeneca's Citizen Petition surrounding the company's concern about the approval of any generic version of Pulmicort Respules (budesonide inhalation suspension). While the FDA...
WOODCLIFF LAKE, N.J., November 14, 2008/PRNewswire/ --Eisai Corporation of North America announced today that the U.S. Food and Drug Administration (FDA) approved Banzel (rufinamide) for the adjunctive treatment of seizures associated with...
COLLEGEVILLE, Pa., Nov. 13 /PRNewswire-FirstCall/ -- Premarin (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S. Food and Drug Administration (FDA) for a new indication and a new less frequent twice-weekly dosing regimen to...
New Drug Applications
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 21, 2008 - Dyax Corp. (NASDAQ: DYAX) announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's Biologics License Application (BLA) for DX-88 (ecallantide) for the...
REINACH, Switzerland, November 20, 2008 /PRNewswire-FirstCall/ -- Arpida announced today that the Anti-infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted 17 to 2 against the approval of intravenous iclaprim,...
LONDON and BRENTWOOD, TN, Nov. 20, 2008 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, today announces that it has commenced the submission of a rolling Biologics...
BRIDGEWATER, N.J., November 20, 2008 /PRNewswire/ -- Ortho Biotech Products, L.P. today announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for trabectedin when administered in combination with...
SOUTH SAN FRANCISCO, CA - NOVEMBER 19, 2008 - Theravance, Inc. announced today that telavancin received a favorable recommendation from the Anti-Infective Drugs Advisory Committee (AIDAC) of the U.S. Food and Drug Administration (FDA) for the...
Clinical Trials
Strasbourg, France, November 21, 2008 – Transgene (Euronext Paris: FR0005175080) today announced that the primary end point has been met in the first step of the ongoing Phase II trial with its immunotherapy product TG1042 (Ad-IFN•) in...
PRINCETON, N.J.--(BUSINESS WIRE)--Nov 21, 2008 - A first-ever 208-person study comparing the renal safety, occurrence of cardiovascular adverse events and diagnostic image quality of GE Healthcare's isosmolar contrast media (CM) iodixanol...
HOUSTON, Nov. 20, 2008--Gefitinib, also known as Iressa, the once-promising targeted therapy for the treatment of non-small cell lung cancer, has proven as effective as chemotherapy as a second-line therapy for the disease with far fewer side...
HOUSTON & LAS VEGAS--(BUSINESS WIRE)--Nov 21, 2008 - Today at the 13th Annual Scientific Meeting of the Society for Neuro-Oncology, BRI announced encouraging results from the ongoing Phase II clinical trials of two of its investigational drugs,...
NATIONAL HARBOR, Md.--(BUSINESS WIRE)--Nov 21, 2008 - New data presented at the 61st Annual Scientific Meeting of the Gerontological Society of America showed JANUVIA™ (sitagliptin), a diabetes medicine from Merck & Co., Inc.,...
More News Resources
Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
